Cytogenetic analysis in human bone marrow transplantation. 1996

E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
Departamento de Genética do Setor de Ciøncias Biológicas, Hospital de Clínicas, Universidade Federal do Paraná, Brazil.

Bone marrow transplantation (BMT) is a therapeutic process used to treat a variety of hematologic diseases. After BMT, the documentation of engrafting with the use of genetic markers is obligatory. C-band polymorphism is an excellent genetic marker because it occurs with high frequency in all populations studied and shows a high stability in vitro and in vivo. We studied a total of 36 patients: 15 with myeloid leukemia and 21 with severe aplastic anemia (SAA), submitted to BMT. The majority of the patients with chronic granulocyte leukemia (CGL; 10/15, 67%) and with SAA (17/21, 81%) showed a frequency of host cells around 15% (CGL) and 8% (SAA) in the first period analyzed (day +30 post-BMT); with a decrease in the others (+90, +180 to CGL and SAA and +365 only to CGL). In our study, the persistence of host cells in these proportions did not imply an unfavorable prognosis. On the contrary, some patients with myeloid leukemia (5/15 33%) and SAA (4/21, 19%) showed high proportions of host cells in one or more periods analyzed. If compared to the first group, these patients had, in general, a poor clinical evolution, with rejections, relapses, and deaths in greater numbers. These results show the important contribution of cytogenetic analysis in the follow-up of patients submitted to BMT.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias

Related Publications

E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
December 1981, Cancer genetics and cytogenetics,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
February 1986, Cancer genetics and cytogenetics,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
August 1990, British journal of haematology,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
August 2001, BMJ (Clinical research ed.),
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
January 1994, Cancer genetics and cytogenetics,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
March 1972, The Medical clinics of North America,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
April 1990, European journal of clinical investigation,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
August 1979, Ugeskrift for laeger,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
September 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
E M Ribeiro, and I J Cavalli, and A T Schmid, and D A Cornélio, and A S Tokutake, and V M Sperandio-Roxo, and J M Rodriguez, and R Pasquini
January 2001, Cancer genetics and cytogenetics,
Copied contents to your clipboard!